The Longevity Genes in Founder Populations Project

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

NCT Number	NCT00707694
Lead Sponsor	Albert Einstein College of Medicine Collaborators: National Institute on Aging (NIA), American Federation for Aging Research, Weill Medical College of Cornell University, Boston University, Regeneron Pharmaceuticals, Harvard Medical School (HMS and HSDM), Stanford University, Tufts Medical Center, Columbia University, University of Minnesota, Rutgers Health, University of Rochester
Conditions	Extreme Longevity
Enrollment	2,000 participants
Start Date	1998-07
Primary Completion	2032-12 (estimated)
Study Completion	2032-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-02